SCHEMBL11889641

SCHEMBL11889641

CC(=O)Oc1ccc(NC(=O)c2ccc(N3CCN(C(=O)OC(C)(C)C)CC3)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.59
SMN1; SMN2 Q16637 6/20 0.59
KMT2A Q03164 5/20 0.59
USP2 O75604 3/20 0.59
MEN1 O00255 3/20 0.59
HSD17B10 Q99714 2/20 0.59
TSHR P16473 1/20 0.59
TP53 P04637 1/20 0.59
MAPK1 P28482 1/20 0.59
LMNA P02545 2/20 0.58
NAMPT P43490 1/20 0.57
ALDH1A1 P00352 5/20 0.56
HIF1A Q16665 1/20 0.56
CYP2C19 P33261 2/20 0.56
CYP2C9 P11712 1/20 0.56
HPGD P15428 1/20 0.56
RAB9A P51151 3/20 0.55
NPC1 O15118 2/20 0.55
KDM4E B2RXH2 2/20 0.54
HTT P42858 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29803251 0.91 MAPT (0.69) MAPTSMN1; SMN2KMT2AUSP2MEN1
SCHEMBL30182423 0.91 MAPT (0.69) MAPTSMN1; SMN2KMT2AUSP2MEN1
SCHEMBL2458130 0.90 NAMPT (0.55) MAPTSMN1; SMN2KMT2AUSP2MEN1
SCHEMBL11889698 0.87 MAPT (0.61) MAPTSMN1; SMN2KMT2AUSP2MEN1
SCHEMBL24891887 0.87 MAPT (0.64) MAPTSMN1; SMN2KMT2AUSP2MEN1
SCHEMBL11960760 0.87 KMT2A (0.71) MAPTSMN1; SMN2KMT2AUSP2MEN1
SCHEMBL2454198 0.87 MAPT (0.64) MAPTSMN1; SMN2KMT2AUSP2MEN1
SCHEMBL2455257 0.87 MAPT (0.64) MAPTSMN1; SMN2KMT2AUSP2MEN1
SCHEMBL11889653 0.86 NPC1 (0.64) MAPTSMN1; SMN2KMT2AUSP2MEN1
SCHEMBL2451687 0.86 KMT2A (0.64) MAPTSMN1; SMN2KMT2AUSP2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799663-B1 Modulators of HCV replication ANGELETTI P IST RICHERCHE BIO (IT) 2012-08-01 EP disclosed
US-8012982-B2 Modulators of HCV replication ISTITUTO DI RICERCHE BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-09-06 US disclosed
US-20090069344-A1 Modulators of hcv replication ISTITUTO DI RICERCHE BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069344-A1 Modulators of hcv replication EIF2AK2, IRF3, IFNAR1 MAPT 4662/4885SMN1; SMN2 4644/4885KMT2A 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.